Avricore Health Inc. (AVCR.V)
CAD 0.05
(0.0%)
CAD 0.05
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.53 Million CAD | -1.2% |
| 2022 | 2.56 Million CAD | 12.61% |
| 2021 | 2.28 Million CAD | 418.39% |
| 2020 | 440.09 Thousand CAD | 111.18% |
| 2019 | 208.39 Thousand CAD | -82.64% |
| 2018 | 1.2 Million CAD | -58.62% |
| 2017 | 2.9 Million CAD | 27.46% |
| 2016 | 2.27 Million CAD | -34.86% |
| 2015 | 3.49 Million CAD | -1.34% |
| 2014 | 3.54 Million CAD | 331.56% |
| 2013 | 820.41 Thousand CAD | 2.43% |
| 2012 | 800.99 Thousand CAD | 3955.45% |
| 2011 | 19.75 Thousand CAD | -89.63% |
| 2010 | 190.49 Thousand CAD | -85.92% |
| 2009 | 1.35 Million CAD | -24.07% |
| 2008 | 1.78 Million CAD | -29.67% |
| 2007 | 2.53 Million CAD | 196.66% |
| 2006 | 854.16 Thousand CAD | 293.86% |
| 2005 | 216.87 Thousand CAD | -27.92% |
| 2004 | 300.89 Thousand CAD | -63.78% |
| 2003 | 830.76 Thousand CAD | 189.93% |
| 2002 | 286.54 Thousand CAD | 50.99% |
| 2001 | 189.77 Thousand CAD | 125.97% |
| 2000 | 83.98 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2.61 Million CAD | -6.42% |
| 2024 Q1 | 2.79 Million CAD | 10.24% |
| 2023 Q3 | 2.45 Million CAD | 14.43% |
| 2023 Q4 | 2.53 Million CAD | 3.47% |
| 2023 Q1 | 2.29 Million CAD | -10.6% |
| 2023 Q2 | 2.14 Million CAD | -6.65% |
| 2023 FY | 2.53 Million CAD | -1.2% |
| 2022 Q1 | 2.12 Million CAD | -6.95% |
| 2022 FY | 2.56 Million CAD | 12.61% |
| 2022 Q4 | 2.56 Million CAD | 20.72% |
| 2022 Q3 | 2.12 Million CAD | 7.2% |
| 2022 Q2 | 1.98 Million CAD | -6.49% |
| 2021 FY | 2.28 Million CAD | 418.39% |
| 2021 Q4 | 2.28 Million CAD | -9.38% |
| 2021 Q1 | 2.74 Million CAD | 522.61% |
| 2021 Q2 | 2.54 Million CAD | -7.26% |
| 2021 Q3 | 2.51 Million CAD | -0.93% |
| 2020 Q3 | 355.8 Thousand CAD | -33.13% |
| 2020 Q1 | 607.06 Thousand CAD | 191.3% |
| 2020 Q4 | 440.09 Thousand CAD | 23.69% |
| 2020 Q2 | 532.08 Thousand CAD | -12.35% |
| 2020 FY | 440.09 Thousand CAD | 111.18% |
| 2019 Q1 | 970.18 Thousand CAD | -19.16% |
| 2019 Q2 | 649.3 Thousand CAD | -33.07% |
| 2019 Q3 | 410.95 Thousand CAD | -36.71% |
| 2019 Q4 | 208.39 Thousand CAD | -49.29% |
| 2019 FY | 208.39 Thousand CAD | -82.64% |
| 2018 Q3 | 2.81 Million CAD | -2.36% |
| 2018 FY | 1.2 Million CAD | -58.62% |
| 2018 Q4 | 1.2 Million CAD | -57.36% |
| 2018 Q2 | 2.88 Million CAD | 16.88% |
| 2018 Q1 | 2.46 Million CAD | -14.95% |
| 2017 Q3 | 1.41 Million CAD | -35.68% |
| 2017 Q4 | 2.9 Million CAD | 104.36% |
| 2017 FY | 2.9 Million CAD | 27.46% |
| 2017 Q1 | 1.65 Million CAD | -27.32% |
| 2017 Q2 | 2.2 Million CAD | 33.42% |
| 2016 Q4 | 2.27 Million CAD | -29.06% |
| 2016 Q3 | 3.2 Million CAD | -5.18% |
| 2016 Q2 | 3.38 Million CAD | -8.99% |
| 2016 FY | 2.27 Million CAD | -34.86% |
| 2016 Q1 | 3.71 Million CAD | 6.4% |
| 2015 Q2 | 3.54 Million CAD | 0.72% |
| 2015 FY | 3.49 Million CAD | -1.34% |
| 2015 Q4 | 3.49 Million CAD | 6.44% |
| 2015 Q1 | 3.51 Million CAD | 137.59% |
| 2015 Q3 | 3.28 Million CAD | -7.31% |
| 2014 Q3 | 614.26 Thousand CAD | -25.13% |
| 2014 FY | 3.54 Million CAD | 331.56% |
| 2014 Q2 | 820.41 Thousand CAD | -7.62% |
| 2014 Q1 | 888.04 Thousand CAD | 7.49% |
| 2014 Q4 | 1.47 Million CAD | 140.87% |
| 2013 Q3 | 954.53 Thousand CAD | 19.17% |
| 2013 FY | 820.41 Thousand CAD | 2.43% |
| 2013 Q1 | 354.42 Thousand CAD | -3.06% |
| 2013 Q2 | 800.99 Thousand CAD | 126.0% |
| 2013 Q4 | 826.17 Thousand CAD | -13.45% |
| 2012 FY | 800.99 Thousand CAD | 3955.45% |
| 2012 Q4 | 365.61 Thousand CAD | 0.95% |
| 2012 Q3 | 362.16 Thousand CAD | 1733.67% |
| 2012 Q2 | 19.75 Thousand CAD | -74.01% |
| 2012 Q1 | 75.99 Thousand CAD | -26.16% |
| 2011 FY | 19.75 Thousand CAD | -89.63% |
| 2011 Q4 | 102.91 Thousand CAD | -24.23% |
| 2011 Q2 | 190.49 Thousand CAD | -80.71% |
| 2011 Q1 | 987.75 Thousand CAD | -1.82% |
| 2011 Q3 | 135.82 Thousand CAD | -28.7% |
| 2010 FY | 190.49 Thousand CAD | -85.92% |
| 2010 Q1 | 1.46 Million CAD | -55.14% |
| 2010 Q3 | 1.24 Million CAD | -8.25% |
| 2010 Q4 | 1 Million CAD | -18.96% |
| 2010 Q2 | 1.35 Million CAD | -7.5% |
| 2009 Q4 | 3.26 Million CAD | 0.0% |
| 2009 FY | 1.35 Million CAD | -24.07% |
| 2009 Q1 | 1.94 Million CAD | -9.68% |
| 2009 Q2 | 1.78 Million CAD | -8.39% |
| 2008 Q3 | 2.34 Million CAD | -7.56% |
| 2008 Q1 | 2.69 Million CAD | 38.54% |
| 2008 FY | 1.78 Million CAD | -29.67% |
| 2008 Q4 | 2.15 Million CAD | -8.05% |
| 2008 Q2 | 2.53 Million CAD | -6.01% |
| 2007 Q3 | 1.25 Million CAD | 47.01% |
| 2007 Q2 | 854.16 Thousand CAD | 384.45% |
| 2007 Q1 | 176.31 Thousand CAD | 0.33% |
| 2007 Q4 | 1.94 Million CAD | 54.98% |
| 2007 FY | 2.53 Million CAD | 196.66% |
| 2006 FY | 854.16 Thousand CAD | 293.86% |
| 2006 Q1 | 207.8 Thousand CAD | -33.44% |
| 2006 Q2 | 216.87 Thousand CAD | 4.37% |
| 2006 Q4 | 175.74 Thousand CAD | -15.64% |
| 2006 Q3 | 208.32 Thousand CAD | -3.94% |
| 2005 FY | 216.87 Thousand CAD | -27.92% |
| 2005 Q2 | 300.89 Thousand CAD | -55.68% |
| 2005 Q1 | 678.88 Thousand CAD | 20.05% |
| 2005 Q3 | 237.14 Thousand CAD | -21.19% |
| 2005 Q4 | 312.19 Thousand CAD | 31.65% |
| 2004 Q3 | 687.82 Thousand CAD | -17.21% |
| 2004 Q1 | 1.2 Million CAD | -12.85% |
| 2004 Q2 | 830.76 Thousand CAD | -30.92% |
| 2004 FY | 300.89 Thousand CAD | -63.78% |
| 2004 Q4 | 565.52 Thousand CAD | -17.78% |
| 2003 Q4 | 1.37 Million CAD | 222.63% |
| 2003 Q1 | 162 Thousand CAD | 0.77% |
| 2003 Q2 | 286.54 Thousand CAD | 76.88% |
| 2003 FY | 830.76 Thousand CAD | 189.93% |
| 2003 Q3 | 427.71 Thousand CAD | 49.27% |
| 2002 Q4 | 160.76 Thousand CAD | -10.56% |
| 2002 Q3 | 179.75 Thousand CAD | 0.0% |
| 2002 FY | 286.54 Thousand CAD | 50.99% |
| 2001 FY | 189.77 Thousand CAD | 125.97% |
| 2000 FY | 83.98 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Telo Genomics Corp. | 965.64 Thousand CAD | -162.851% |